Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy

This study has been completed.
Information provided by (Responsible Party):
Wei Shi, Guangdong General Hospital Identifier:
First received: January 23, 2007
Last updated: August 27, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):